학술논문
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
Document Type
Article
Author
Rischin, D.; Lim, A.M.; Hughes, B.G.M.; Basset-Séguin, N.; Schadendorf, D.; Bowyer, S.; Trabelsi Messai, S.; Meier, F.; Eigentler, T.K.; Casado Echarren, V.; Stein, B.; Beylot-Barry, M.; Dalac, S.; Dréno, B.; Migden, M.R.; Hausschild, A.; Schmults, C.D.; Yoo, S.-Y.; Paccaly, A.J.; Papachristos, A.; Nguyen, J.-H.; Okoye, E.; Seebach, F.; Booth, J.; Lowy, I.; Fury, M.G.; Guminski, A.
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 11 March 2024, 12(3))
Subject
Language
English
ISSN
20511426